 | • レポートコード：GIR-23F3562 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医療機器 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Non-alcoholic Steatohepatitis Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の非アルコール性脂肪性肝炎の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 非アルコール性脂肪性肝炎市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・固体状、液体状 アプリケーション別セグメントは次のように区分されます。 ・経口、非経口 世界の非アルコール性脂肪性肝炎市場の主要なマーケットプレーヤーは以下のとおりです。 ・AstraZeneca、Arena Pharmaceuticals、GSK、Novo Nordisk、Roche、Vivus、Arisaph Pharmaceuticals、Cempra Pharmaceuticals、Galectin Therapeutics、Galmed Pharmaceuticals、Genfit、Gilead、Immuron、Interceptpharma、Raptor Pharmaceutical、Takeda、Tobira Therapeutics、Verva、Viking Therapeutics 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 非アルコール性脂肪性肝炎の概要 - タイプ別分析（2017年vs2021年vs2028年）：固体状、液体状 - アプリケーション別分析（2017年vs2021年vs2028年）：経口、非経口 - 世界の非アルコール性脂肪性肝炎市場規模・予測 - 世界の非アルコール性脂肪性肝炎生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - AstraZeneca、Arena Pharmaceuticals、GSK、Novo Nordisk、Roche、Vivus、Arisaph Pharmaceuticals、Cempra Pharmaceuticals、Galectin Therapeutics、Galmed Pharmaceuticals、Genfit、Gilead、Immuron、Interceptpharma、Raptor Pharmaceutical、Takeda、Tobira Therapeutics、Verva、Viking Therapeutics ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：固体状、液体状 ・アプリケーション別分析2017年-2028年：経口、非経口 ・非アルコール性脂肪性肝炎の北米市場分析 - 非アルコール性脂肪性肝炎の北米市場：タイプ別市場規模2017年-2028年 - 非アルコール性脂肪性肝炎の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・非アルコール性脂肪性肝炎のヨーロッパ市場分析 - ：非アルコール性脂肪性肝炎のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：非アルコール性脂肪性肝炎のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・非アルコール性脂肪性肝炎のアジア太平洋市場分析 - 非アルコール性脂肪性肝炎のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 非アルコール性脂肪性肝炎のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・非アルコール性脂肪性肝炎の南米市場分析 - 非アルコール性脂肪性肝炎の南米市場：タイプ別市場規模2017年-2028年 - 非アルコール性脂肪性肝炎の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・非アルコール性脂肪性肝炎の中東・アフリカ市場分析 - 非アルコール性脂肪性肝炎の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 非アルコール性脂肪性肝炎の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Non-alcoholic Steatohepatitis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Non-alcoholic Steatohepatitis market size is estimated to be worth US$ 3277.4 million in 2021 and is forecast to a readjusted size of USD 11540 million by 2028 with a CAGR of 19.7% during review period. Oral accounting for % of the Non-alcoholic Steatohepatitis global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Solid segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Non-alcoholic Steatohepatitis include AstraZeneca, Arena Pharmaceuticals, GSK, Novo Nordisk, and Roche, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Non-alcoholic Steatohepatitis market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Solid
Liquid
Market segment by Application can be divided into
Oral
Parenteral
The key market players for global Non-alcoholic Steatohepatitis market are listed below:
AstraZeneca
Arena Pharmaceuticals
GSK
Novo Nordisk
Roche
Vivus
Arisaph Pharmaceuticals
Cempra Pharmaceuticals
Galectin Therapeutics
Galmed Pharmaceuticals
Genfit
Gilead
Immuron
Interceptpharma
Raptor Pharmaceutical
Takeda
Tobira Therapeutics
Verva
Viking Therapeutics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-alcoholic Steatohepatitis product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Non-alcoholic Steatohepatitis, with price, sales, revenue and global market share of Non-alcoholic Steatohepatitis from 2019 to 2022.
Chapter 3, the Non-alcoholic Steatohepatitis competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-alcoholic Steatohepatitis breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Non-alcoholic Steatohepatitis market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-alcoholic Steatohepatitis.
Chapter 13, 14, and 15, to describe Non-alcoholic Steatohepatitis sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Non-alcoholic Steatohepatitis Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Non-alcoholic Steatohepatitis Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Solid
1.2.3 Liquid
1.3 Market Analysis by Application
1.3.1 Overview: Global Non-alcoholic Steatohepatitis Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oral
1.3.3 Parenteral
1.4 Global Non-alcoholic Steatohepatitis Market Size & Forecast
1.4.1 Global Non-alcoholic Steatohepatitis Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Non-alcoholic Steatohepatitis Sales in Volume (2017-2028)
1.4.3 Global Non-alcoholic Steatohepatitis Price (2017-2028)
1.5 Global Non-alcoholic Steatohepatitis Production Capacity Analysis
1.5.1 Global Non-alcoholic Steatohepatitis Total Production Capacity (2017-2028)
1.5.2 Global Non-alcoholic Steatohepatitis Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Non-alcoholic Steatohepatitis Market Drivers
1.6.2 Non-alcoholic Steatohepatitis Market Restraints
1.6.3 Non-alcoholic Steatohepatitis Trends Analysis
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Non-alcoholic Steatohepatitis Product and Services
2.1.4 AstraZeneca Non-alcoholic Steatohepatitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Arena Pharmaceuticals
2.2.1 Arena Pharmaceuticals Details
2.2.2 Arena Pharmaceuticals Major Business
2.2.3 Arena Pharmaceuticals Non-alcoholic Steatohepatitis Product and Services
2.2.4 Arena Pharmaceuticals Non-alcoholic Steatohepatitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Non-alcoholic Steatohepatitis Product and Services
2.3.4 GSK Non-alcoholic Steatohepatitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Novo Nordisk
2.4.1 Novo Nordisk Details
2.4.2 Novo Nordisk Major Business
2.4.3 Novo Nordisk Non-alcoholic Steatohepatitis Product and Services
2.4.4 Novo Nordisk Non-alcoholic Steatohepatitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Non-alcoholic Steatohepatitis Product and Services
2.5.4 Roche Non-alcoholic Steatohepatitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Vivus
2.6.1 Vivus Details
2.6.2 Vivus Major Business
2.6.3 Vivus Non-alcoholic Steatohepatitis Product and Services
2.6.4 Vivus Non-alcoholic Steatohepatitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Arisaph Pharmaceuticals
2.7.1 Arisaph Pharmaceuticals Details
2.7.2 Arisaph Pharmaceuticals Major Business
2.7.3 Arisaph Pharmaceuticals Non-alcoholic Steatohepatitis Product and Services
2.7.4 Arisaph Pharmaceuticals Non-alcoholic Steatohepatitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Cempra Pharmaceuticals
2.8.1 Cempra Pharmaceuticals Details
2.8.2 Cempra Pharmaceuticals Major Business
2.8.3 Cempra Pharmaceuticals Non-alcoholic Steatohepatitis Product and Services
2.8.4 Cempra Pharmaceuticals Non-alcoholic Steatohepatitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Galectin Therapeutics
2.9.1 Galectin Therapeutics Details
2.9.2 Galectin Therapeutics Major Business
2.9.3 Galectin Therapeutics Non-alcoholic Steatohepatitis Product and Services
2.9.4 Galectin Therapeutics Non-alcoholic Steatohepatitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Galmed Pharmaceuticals
2.10.1 Galmed Pharmaceuticals Details
2.10.2 Galmed Pharmaceuticals Major Business
2.10.3 Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Product and Services
2.10.4 Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Genfit
2.11.1 Genfit Details
2.11.2 Genfit Major Business
2.11.3 Genfit Non-alcoholic Steatohepatitis Product and Services
2.11.4 Genfit Non-alcoholic Steatohepatitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Gilead
2.12.1 Gilead Details
2.12.2 Gilead Major Business
2.12.3 Gilead Non-alcoholic Steatohepatitis Product and Services
2.12.4 Gilead Non-alcoholic Steatohepatitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Immuron
2.13.1 Immuron Details
2.13.2 Immuron Major Business
2.13.3 Immuron Non-alcoholic Steatohepatitis Product and Services
2.13.4 Immuron Non-alcoholic Steatohepatitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Interceptpharma
2.14.1 Interceptpharma Details
2.14.2 Interceptpharma Major Business
2.14.3 Interceptpharma Non-alcoholic Steatohepatitis Product and Services
2.14.4 Interceptpharma Non-alcoholic Steatohepatitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Raptor Pharmaceutical
2.15.1 Raptor Pharmaceutical Details
2.15.2 Raptor Pharmaceutical Major Business
2.15.3 Raptor Pharmaceutical Non-alcoholic Steatohepatitis Product and Services
2.15.4 Raptor Pharmaceutical Non-alcoholic Steatohepatitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Takeda
2.16.1 Takeda Details
2.16.2 Takeda Major Business
2.16.3 Takeda Non-alcoholic Steatohepatitis Product and Services
2.16.4 Takeda Non-alcoholic Steatohepatitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Tobira Therapeutics
2.17.1 Tobira Therapeutics Details
2.17.2 Tobira Therapeutics Major Business
2.17.3 Tobira Therapeutics Non-alcoholic Steatohepatitis Product and Services
2.17.4 Tobira Therapeutics Non-alcoholic Steatohepatitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Verva
2.18.1 Verva Details
2.18.2 Verva Major Business
2.18.3 Verva Non-alcoholic Steatohepatitis Product and Services
2.18.4 Verva Non-alcoholic Steatohepatitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Viking Therapeutics
2.19.1 Viking Therapeutics Details
2.19.2 Viking Therapeutics Major Business
2.19.3 Viking Therapeutics Non-alcoholic Steatohepatitis Product and Services
2.19.4 Viking Therapeutics Non-alcoholic Steatohepatitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Non-alcoholic Steatohepatitis Breakdown Data by Manufacturer
3.1 Global Non-alcoholic Steatohepatitis Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Non-alcoholic Steatohepatitis Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Non-alcoholic Steatohepatitis
3.4 Market Concentration Rate
3.4.1 Top 3 Non-alcoholic Steatohepatitis Manufacturer Market Share in 2021
3.4.2 Top 6 Non-alcoholic Steatohepatitis Manufacturer Market Share in 2021
3.5 Global Non-alcoholic Steatohepatitis Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Non-alcoholic Steatohepatitis Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Non-alcoholic Steatohepatitis Market Size by Region
4.1.1 Global Non-alcoholic Steatohepatitis Sales in Volume by Region (2017-2028)
4.1.2 Global Non-alcoholic Steatohepatitis Revenue by Region (2017-2028)
4.2 North America Non-alcoholic Steatohepatitis Revenue (2017-2028)
4.3 Europe Non-alcoholic Steatohepatitis Revenue (2017-2028)
4.4 Asia-Pacific Non-alcoholic Steatohepatitis Revenue (2017-2028)
4.5 South America Non-alcoholic Steatohepatitis Revenue (2017-2028)
4.6 Middle East and Africa Non-alcoholic Steatohepatitis Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Non-alcoholic Steatohepatitis Sales in Volume by Type (2017-2028)
5.2 Global Non-alcoholic Steatohepatitis Revenue by Type (2017-2028)
5.3 Global Non-alcoholic Steatohepatitis Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Non-alcoholic Steatohepatitis Sales in Volume by Application (2017-2028)
6.2 Global Non-alcoholic Steatohepatitis Revenue by Application (2017-2028)
6.3 Global Non-alcoholic Steatohepatitis Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Non-alcoholic Steatohepatitis Sales by Type (2017-2028)
7.2 North America Non-alcoholic Steatohepatitis Sales by Application (2017-2028)
7.3 North America Non-alcoholic Steatohepatitis Market Size by Country
7.3.1 North America Non-alcoholic Steatohepatitis Sales in Volume by Country (2017-2028)
7.3.2 North America Non-alcoholic Steatohepatitis Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Non-alcoholic Steatohepatitis Sales by Type (2017-2028)
8.2 Europe Non-alcoholic Steatohepatitis Sales by Application (2017-2028)
8.3 Europe Non-alcoholic Steatohepatitis Market Size by Country
8.3.1 Europe Non-alcoholic Steatohepatitis Sales in Volume by Country (2017-2028)
8.3.2 Europe Non-alcoholic Steatohepatitis Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Non-alcoholic Steatohepatitis Sales by Type (2017-2028)
9.2 Asia-Pacific Non-alcoholic Steatohepatitis Sales by Application (2017-2028)
9.3 Asia-Pacific Non-alcoholic Steatohepatitis Market Size by Region
9.3.1 Asia-Pacific Non-alcoholic Steatohepatitis Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Non-alcoholic Steatohepatitis Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Non-alcoholic Steatohepatitis Sales by Type (2017-2028)
10.2 South America Non-alcoholic Steatohepatitis Sales by Application (2017-2028)
10.3 South America Non-alcoholic Steatohepatitis Market Size by Country
10.3.1 South America Non-alcoholic Steatohepatitis Sales in Volume by Country (2017-2028)
10.3.2 South America Non-alcoholic Steatohepatitis Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Non-alcoholic Steatohepatitis Sales by Type (2017-2028)
11.2 Middle East & Africa Non-alcoholic Steatohepatitis Sales by Application (2017-2028)
11.3 Middle East & Africa Non-alcoholic Steatohepatitis Market Size by Country
11.3.1 Middle East & Africa Non-alcoholic Steatohepatitis Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Non-alcoholic Steatohepatitis Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Non-alcoholic Steatohepatitis and Key Manufacturers
12.2 Manufacturing Costs Percentage of Non-alcoholic Steatohepatitis
12.3 Non-alcoholic Steatohepatitis Production Process
12.4 Non-alcoholic Steatohepatitis Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Non-alcoholic Steatohepatitis Typical Distributors
13.3 Non-alcoholic Steatohepatitis Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Non-alcoholic Steatohepatitis Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Non-alcoholic Steatohepatitis Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Non-alcoholic Steatohepatitis Product and Services
Table 6. AstraZeneca Non-alcoholic Steatohepatitis Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Arena Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Arena Pharmaceuticals Major Business
Table 9. Arena Pharmaceuticals Non-alcoholic Steatohepatitis Product and Services
Table 10. Arena Pharmaceuticals Non-alcoholic Steatohepatitis Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. GSK Basic Information, Manufacturing Base and Competitors
Table 12. GSK Major Business
Table 13. GSK Non-alcoholic Steatohepatitis Product and Services
Table 14. GSK Non-alcoholic Steatohepatitis Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 16. Novo Nordisk Major Business
Table 17. Novo Nordisk Non-alcoholic Steatohepatitis Product and Services
Table 18. Novo Nordisk Non-alcoholic Steatohepatitis Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Roche Basic Information, Manufacturing Base and Competitors
Table 20. Roche Major Business
Table 21. Roche Non-alcoholic Steatohepatitis Product and Services
Table 22. Roche Non-alcoholic Steatohepatitis Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Vivus Basic Information, Manufacturing Base and Competitors
Table 24. Vivus Major Business
Table 25. Vivus Non-alcoholic Steatohepatitis Product and Services
Table 26. Vivus Non-alcoholic Steatohepatitis Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Arisaph Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. Arisaph Pharmaceuticals Major Business
Table 29. Arisaph Pharmaceuticals Non-alcoholic Steatohepatitis Product and Services
Table 30. Arisaph Pharmaceuticals Non-alcoholic Steatohepatitis Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Cempra Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Cempra Pharmaceuticals Major Business
Table 33. Cempra Pharmaceuticals Non-alcoholic Steatohepatitis Product and Services
Table 34. Cempra Pharmaceuticals Non-alcoholic Steatohepatitis Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Galectin Therapeutics Basic Information, Manufacturing Base and Competitors
Table 36. Galectin Therapeutics Major Business
Table 37. Galectin Therapeutics Non-alcoholic Steatohepatitis Product and Services
Table 38. Galectin Therapeutics Non-alcoholic Steatohepatitis Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Galmed Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Galmed Pharmaceuticals Major Business
Table 41. Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Product and Services
Table 42. Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Genfit Basic Information, Manufacturing Base and Competitors
Table 44. Genfit Major Business
Table 45. Genfit Non-alcoholic Steatohepatitis Product and Services
Table 46. Genfit Non-alcoholic Steatohepatitis Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Gilead Basic Information, Manufacturing Base and Competitors
Table 48. Gilead Major Business
Table 49. Gilead Non-alcoholic Steatohepatitis Product and Services
Table 50. Gilead Non-alcoholic Steatohepatitis Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Immuron Basic Information, Manufacturing Base and Competitors
Table 52. Immuron Major Business
Table 53. Immuron Non-alcoholic Steatohepatitis Product and Services
Table 54. Immuron Non-alcoholic Steatohepatitis Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Interceptpharma Basic Information, Manufacturing Base and Competitors
Table 56. Interceptpharma Major Business
Table 57. Interceptpharma Non-alcoholic Steatohepatitis Product and Services
Table 58. Interceptpharma Non-alcoholic Steatohepatitis Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Raptor Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. Raptor Pharmaceutical Major Business
Table 61. Raptor Pharmaceutical Non-alcoholic Steatohepatitis Product and Services
Table 62. Raptor Pharmaceutical Non-alcoholic Steatohepatitis Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Takeda Basic Information, Manufacturing Base and Competitors
Table 64. Takeda Major Business
Table 65. Takeda Non-alcoholic Steatohepatitis Product and Services
Table 66. Takeda Non-alcoholic Steatohepatitis Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Tobira Therapeutics Basic Information, Manufacturing Base and Competitors
Table 68. Tobira Therapeutics Major Business
Table 69. Tobira Therapeutics Non-alcoholic Steatohepatitis Product and Services
Table 70. Tobira Therapeutics Non-alcoholic Steatohepatitis Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Verva Basic Information, Manufacturing Base and Competitors
Table 72. Verva Major Business
Table 73. Verva Non-alcoholic Steatohepatitis Product and Services
Table 74. Verva Non-alcoholic Steatohepatitis Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Viking Therapeutics Basic Information, Manufacturing Base and Competitors
Table 76. Viking Therapeutics Major Business
Table 77. Viking Therapeutics Non-alcoholic Steatohepatitis Product and Services
Table 78. Viking Therapeutics Non-alcoholic Steatohepatitis Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Global Non-alcoholic Steatohepatitis Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 80. Global Non-alcoholic Steatohepatitis Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 81. Market Position of Manufacturers in Non-alcoholic Steatohepatitis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 82. Global Non-alcoholic Steatohepatitis Production Capacity by Company, (MT): 2020 VS 2021
Table 83. Head Office and Non-alcoholic Steatohepatitis Production Site of Key Manufacturer
Table 84. Non-alcoholic Steatohepatitis New Entrant and Capacity Expansion Plans
Table 85. Non-alcoholic Steatohepatitis Mergers & Acquisitions in the Past Five Years
Table 86. Global Non-alcoholic Steatohepatitis Sales by Region (2017-2022) & (MT)
Table 87. Global Non-alcoholic Steatohepatitis Sales by Region (2023-2028) & (MT)
Table 88. Global Non-alcoholic Steatohepatitis Revenue by Region (2017-2022) & (USD Million)
Table 89. Global Non-alcoholic Steatohepatitis Revenue by Region (2023-2028) & (USD Million)
Table 90. Global Non-alcoholic Steatohepatitis Sales by Type (2017-2022) & (MT)
Table 91. Global Non-alcoholic Steatohepatitis Sales by Type (2023-2028) & (MT)
Table 92. Global Non-alcoholic Steatohepatitis Revenue by Type (2017-2022) & (USD Million)
Table 93. Global Non-alcoholic Steatohepatitis Revenue by Type (2023-2028) & (USD Million)
Table 94. Global Non-alcoholic Steatohepatitis Price by Type (2017-2022) & (USD/Kg)
Table 95. Global Non-alcoholic Steatohepatitis Price by Type (2023-2028) & (USD/Kg)
Table 96. Global Non-alcoholic Steatohepatitis Sales by Application (2017-2022) & (MT)
Table 97. Global Non-alcoholic Steatohepatitis Sales by Application (2023-2028) & (MT)
Table 98. Global Non-alcoholic Steatohepatitis Revenue by Application (2017-2022) & (USD Million)
Table 99. Global Non-alcoholic Steatohepatitis Revenue by Application (2023-2028) & (USD Million)
Table 100. Global Non-alcoholic Steatohepatitis Price by Application (2017-2022) & (USD/Kg)
Table 101. Global Non-alcoholic Steatohepatitis Price by Application (2023-2028) & (USD/Kg)
Table 102. North America Non-alcoholic Steatohepatitis Sales by Country (2017-2022) & (MT)
Table 103. North America Non-alcoholic Steatohepatitis Sales by Country (2023-2028) & (MT)
Table 104. North America Non-alcoholic Steatohepatitis Revenue by Country (2017-2022) & (USD Million)
Table 105. North America Non-alcoholic Steatohepatitis Revenue by Country (2023-2028) & (USD Million)
Table 106. North America Non-alcoholic Steatohepatitis Sales by Type (2017-2022) & (MT)
Table 107. North America Non-alcoholic Steatohepatitis Sales by Type (2023-2028) & (MT)
Table 108. North America Non-alcoholic Steatohepatitis Sales by Application (2017-2022) & (MT)
Table 109. North America Non-alcoholic Steatohepatitis Sales by Application (2023-2028) & (MT)
Table 110. Europe Non-alcoholic Steatohepatitis Sales by Country (2017-2022) & (MT)
Table 111. Europe Non-alcoholic Steatohepatitis Sales by Country (2023-2028) & (MT)
Table 112. Europe Non-alcoholic Steatohepatitis Revenue by Country (2017-2022) & (USD Million)
Table 113. Europe Non-alcoholic Steatohepatitis Revenue by Country (2023-2028) & (USD Million)
Table 114. Europe Non-alcoholic Steatohepatitis Sales by Type (2017-2022) & (MT)
Table 115. Europe Non-alcoholic Steatohepatitis Sales by Type (2023-2028) & (MT)
Table 116. Europe Non-alcoholic Steatohepatitis Sales by Application (2017-2022) & (MT)
Table 117. Europe Non-alcoholic Steatohepatitis Sales by Application (2023-2028) & (MT)
Table 118. Asia-Pacific Non-alcoholic Steatohepatitis Sales by Region (2017-2022) & (MT)
Table 119. Asia-Pacific Non-alcoholic Steatohepatitis Sales by Region (2023-2028) & (MT)
Table 120. Asia-Pacific Non-alcoholic Steatohepatitis Revenue by Region (2017-2022) & (USD Million)
Table 121. Asia-Pacific Non-alcoholic Steatohepatitis Revenue by Region (2023-2028) & (USD Million)
Table 122. Asia-Pacific Non-alcoholic Steatohepatitis Sales by Type (2017-2022) & (MT)
Table 123. Asia-Pacific Non-alcoholic Steatohepatitis Sales by Type (2023-2028) & (MT)
Table 124. Asia-Pacific Non-alcoholic Steatohepatitis Sales by Application (2017-2022) & (MT)
Table 125. Asia-Pacific Non-alcoholic Steatohepatitis Sales by Application (2023-2028) & (MT)
Table 126. South America Non-alcoholic Steatohepatitis Sales by Country (2017-2022) & (MT)
Table 127. South America Non-alcoholic Steatohepatitis Sales by Country (2023-2028) & (MT)
Table 128. South America Non-alcoholic Steatohepatitis Revenue by Country (2017-2022) & (USD Million)
Table 129. South America Non-alcoholic Steatohepatitis Revenue by Country (2023-2028) & (USD Million)
Table 130. South America Non-alcoholic Steatohepatitis Sales by Type (2017-2022) & (MT)
Table 131. South America Non-alcoholic Steatohepatitis Sales by Type (2023-2028) & (MT)
Table 132. South America Non-alcoholic Steatohepatitis Sales by Application (2017-2022) & (MT)
Table 133. South America Non-alcoholic Steatohepatitis Sales by Application (2023-2028) & (MT)
Table 134. Middle East & Africa Non-alcoholic Steatohepatitis Sales by Region (2017-2022) & (MT)
Table 135. Middle East & Africa Non-alcoholic Steatohepatitis Sales by Region (2023-2028) & (MT)
Table 136. Middle East & Africa Non-alcoholic Steatohepatitis Revenue by Region (2017-2022) & (USD Million)
Table 137. Middle East & Africa Non-alcoholic Steatohepatitis Revenue by Region (2023-2028) & (USD Million)
Table 138. Middle East & Africa Non-alcoholic Steatohepatitis Sales by Type (2017-2022) & (MT)
Table 139. Middle East & Africa Non-alcoholic Steatohepatitis Sales by Type (2023-2028) & (MT)
Table 140. Middle East & Africa Non-alcoholic Steatohepatitis Sales by Application (2017-2022) & (MT)
Table 141. Middle East & Africa Non-alcoholic Steatohepatitis Sales by Application (2023-2028) & (MT)
Table 142. Non-alcoholic Steatohepatitis Raw Material
Table 143. Key Manufacturers of Non-alcoholic Steatohepatitis Raw Materials
Table 144. Direct Channel Pros & Cons
Table 145. Indirect Channel Pros & Cons
Table 146. Non-alcoholic Steatohepatitis Typical Distributors
Table 147. Non-alcoholic Steatohepatitis Typical Customers
List of Figures
Figure 1. Non-alcoholic Steatohepatitis Picture
Figure 2. Global Non-alcoholic Steatohepatitis Revenue Market Share by Type in 2021
Figure 3. Solid
Figure 4. Liquid
Figure 5. Global Non-alcoholic Steatohepatitis Revenue Market Share by Application in 2021
Figure 6. Oral
Figure 7. Parenteral
Figure 8. Global Non-alcoholic Steatohepatitis Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 9. Global Non-alcoholic Steatohepatitis Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Non-alcoholic Steatohepatitis Sales (2017-2028) & (MT)
Figure 11. Global Non-alcoholic Steatohepatitis Price (2017-2028) & (USD/Kg)
Figure 12. Global Non-alcoholic Steatohepatitis Production Capacity (2017-2028) & (MT)
Figure 13. Global Non-alcoholic Steatohepatitis Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Non-alcoholic Steatohepatitis Market Drivers
Figure 15. Non-alcoholic Steatohepatitis Market Restraints
Figure 16. Non-alcoholic Steatohepatitis Market Trends
Figure 17. Global Non-alcoholic Steatohepatitis Sales Market Share by Manufacturer in 2021
Figure 18. Global Non-alcoholic Steatohepatitis Revenue Market Share by Manufacturer in 2021
Figure 19. Non-alcoholic Steatohepatitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Non-alcoholic Steatohepatitis Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Non-alcoholic Steatohepatitis Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Non-alcoholic Steatohepatitis Sales Market Share by Region (2017-2028)
Figure 23. Global Non-alcoholic Steatohepatitis Revenue Market Share by Region (2017-2028)
Figure 24. North America Non-alcoholic Steatohepatitis Revenue (2017-2028) & (USD Million)
Figure 25. Europe Non-alcoholic Steatohepatitis Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Non-alcoholic Steatohepatitis Revenue (2017-2028) & (USD Million)
Figure 27. South America Non-alcoholic Steatohepatitis Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Non-alcoholic Steatohepatitis Revenue (2017-2028) & (USD Million)
Figure 29. Global Non-alcoholic Steatohepatitis Sales Market Share by Type (2017-2028)
Figure 30. Global Non-alcoholic Steatohepatitis Revenue Market Share by Type (2017-2028)
Figure 31. Global Non-alcoholic Steatohepatitis Price by Type (2017-2028) & (USD/Kg)
Figure 32. Global Non-alcoholic Steatohepatitis Sales Market Share by Application (2017-2028)
Figure 33. Global Non-alcoholic Steatohepatitis Revenue Market Share by Application (2017-2028)
Figure 34. Global Non-alcoholic Steatohepatitis Price by Application (2017-2028) & (USD/Kg)
Figure 35. North America Non-alcoholic Steatohepatitis Sales Market Share by Type (2017-2028)
Figure 36. North America Non-alcoholic Steatohepatitis Sales Market Share by Application (2017-2028)
Figure 37. North America Non-alcoholic Steatohepatitis Sales Market Share by Country (2017-2028)
Figure 38. North America Non-alcoholic Steatohepatitis Revenue Market Share by Country (2017-2028)
Figure 39. United States Non-alcoholic Steatohepatitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Non-alcoholic Steatohepatitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Non-alcoholic Steatohepatitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Non-alcoholic Steatohepatitis Sales Market Share by Type (2017-2028)
Figure 43. Europe Non-alcoholic Steatohepatitis Sales Market Share by Application (2017-2028)
Figure 44. Europe Non-alcoholic Steatohepatitis Sales Market Share by Country (2017-2028)
Figure 45. Europe Non-alcoholic Steatohepatitis Revenue Market Share by Country (2017-2028)
Figure 46. Germany Non-alcoholic Steatohepatitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Non-alcoholic Steatohepatitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Non-alcoholic Steatohepatitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Non-alcoholic Steatohepatitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Non-alcoholic Steatohepatitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Non-alcoholic Steatohepatitis Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Non-alcoholic Steatohepatitis Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Non-alcoholic Steatohepatitis Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Non-alcoholic Steatohepatitis Revenue Market Share by Region (2017-2028)
Figure 55. China Non-alcoholic Steatohepatitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Non-alcoholic Steatohepatitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Non-alcoholic Steatohepatitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Non-alcoholic Steatohepatitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Non-alcoholic Steatohepatitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Non-alcoholic Steatohepatitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Non-alcoholic Steatohepatitis Sales Market Share by Type (2017-2028)
Figure 62. South America Non-alcoholic Steatohepatitis Sales Market Share by Application (2017-2028)
Figure 63. South America Non-alcoholic Steatohepatitis Sales Market Share by Country (2017-2028)
Figure 64. South America Non-alcoholic Steatohepatitis Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Non-alcoholic Steatohepatitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Non-alcoholic Steatohepatitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Non-alcoholic Steatohepatitis Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Non-alcoholic Steatohepatitis Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Non-alcoholic Steatohepatitis Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Non-alcoholic Steatohepatitis Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Non-alcoholic Steatohepatitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Non-alcoholic Steatohepatitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Non-alcoholic Steatohepatitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Non-alcoholic Steatohepatitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Non-alcoholic Steatohepatitis in 2021
Figure 76. Manufacturing Process Analysis of Non-alcoholic Steatohepatitis
Figure 77. Non-alcoholic Steatohepatitis Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source